Breaking News

Chugai Opens U.S. Hub in NJ

Facility is dedicated to translational clinical research

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Chugai Pharma USA Inc. (CPUSA), a wholly-owned subsidiary of Chugai Pharmaceutical Co, Ltd. headquartered in Tokyo, has opened its new office in Berkeley Heights, NJ, dedicated to translational clinical research. CPUSA is now focused on Early Development and, in spring of this year established Chugai’s Translational Clinical Research Division (TCRD). TCRD is Chugai’s first global organization composed of functions in Japan, Europe, and the U.S. (CPUSA), dedicated to late preclinic...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters